Clinical Trial Update: Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ofatumumab to rituximab in children with steroid- and calcineurin inhibitor-dependent idiopathic nephrotic syndrome; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• Ofatumumab (ofatumumab)
• Rituximab (rituximab)

Snippet

Sponsor: Istituto Giannina Gaslini | Conditions: Nephrotic Syndrome | Phase 2 | Status: COMPLETED